Yi Feng

4.2k total citations
92 papers, 2.2k citations indexed

About

Yi Feng is a scholar working on Molecular Biology, Nutrition and Dietetics and Cancer Research. According to data from OpenAlex, Yi Feng has authored 92 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 16 papers in Nutrition and Dietetics and 15 papers in Cancer Research. Recurrent topics in Yi Feng's work include Nanoplatforms for cancer theranostics (11 papers), Infant Nutrition and Health (9 papers) and Cancer-related molecular mechanisms research (9 papers). Yi Feng is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), Infant Nutrition and Health (9 papers) and Cancer-related molecular mechanisms research (9 papers). Yi Feng collaborates with scholars based in China, United States and Canada. Yi Feng's co-authors include Chunsheng Li, Zhongyi Hu, Nai‐Kong V. Cheung, Irene Y. Cheung, Wei Cai, Yiyao Liu, Chunhui Wu, George Coukos, Zhang Lin and Hong Yang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Yi Feng

88 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Feng China 29 1.1k 576 358 335 250 92 2.2k
Peng Zhao China 33 1.5k 1.4× 513 0.9× 535 1.5× 339 1.0× 179 0.7× 97 3.4k
Xiaoyue Tan China 29 1.4k 1.3× 482 0.8× 337 0.9× 403 1.2× 471 1.9× 82 3.0k
Xiaoyan Zhou China 29 1.1k 1.0× 496 0.9× 122 0.3× 209 0.6× 262 1.0× 120 2.5k
Rezvan Najafi Iran 27 1.3k 1.2× 680 1.2× 209 0.6× 540 1.6× 222 0.9× 122 2.7k
Raheleh Farahzadi Iran 30 858 0.8× 292 0.5× 179 0.5× 252 0.8× 136 0.5× 78 2.2k
Yongchuan Deng China 24 914 0.9× 427 0.7× 498 1.4× 498 1.5× 311 1.2× 53 2.4k
Jian Yang China 33 2.0k 1.9× 804 1.4× 218 0.6× 315 0.9× 449 1.8× 122 3.2k
T Maeda Japan 19 1.2k 1.1× 452 0.8× 544 1.5× 467 1.4× 121 0.5× 43 2.9k

Countries citing papers authored by Yi Feng

Since Specialization
Citations

This map shows the geographic impact of Yi Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Feng more than expected).

Fields of papers citing papers by Yi Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Feng. The network helps show where Yi Feng may publish in the future.

Co-authorship network of co-authors of Yi Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Feng. A scholar is included among the top collaborators of Yi Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Feng. Yi Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Lei, Yi Feng, Ruoqi Li, et al.. (2024). MiR-134-5p inhibits the malignant phenotypes of osteosarcoma via ITGB1/MMP2/PI3K/Akt pathway. Cell Death Discovery. 10(1). 193–193.
2.
Wang, Lingyu, et al.. (2023). Associations Between Serum TNF-α, IL-6, hs-CRP and GLMD in Obese Children and Adolescents: A Cross-Sectional Study. Diabetes Metabolic Syndrome and Obesity. Volume 16. 3915–3923. 8 indexed citations
3.
Zhang, Yajie, Wenyi Lu, Ji Li, et al.. (2023). Tri-ponderal mass index as a screening tool for obesity prediction in children aged 6–9 years. Frontiers in Endocrinology. 14. 1277125–1277125.
5.
Yan, Lei, Yi Feng, Xiaoyan Li, et al.. (2023). Efficacy and safety of corticosteroids, hyaluronic acid, and PRP and combination therapy for knee osteoarthritis: a systematic review and network meta-analysis. BMC Musculoskeletal Disorders. 24(1). 926–926. 35 indexed citations
6.
Yang, Geng, Ting Song, Meng Wang, et al.. (2022). Recent Advancements in Nanosystem-Based Molecular Beacons for RNA Detection and Imaging. ACS Applied Nano Materials. 5(3). 3065–3086. 16 indexed citations
7.
Feng, Yi, Zhen Liao, Mengyue Li, et al.. (2022). Mesoporous Silica Nanoparticles‐Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics. Advanced Healthcare Materials. 12(16). e2201884–e2201884. 62 indexed citations
8.
Hoseini, Sayed Shahabuddin, Hoa Tran, Yi Feng, et al.. (2021). T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemia. Journal for ImmunoTherapy of Cancer. 9(5). e002509–e002509. 7 indexed citations
9.
Feng, Yi, Xiaoxue Xie, Hanxi Zhang, et al.. (2021). Multistage-responsive nanovehicle to improve tumor penetration for dual-modality imaging-guided photodynamic-immunotherapy. Biomaterials. 275. 120990–120990. 51 indexed citations
10.
Xie, Xiaoxue, Yu Chen, Zhongyuan Chen, et al.. (2019). Polymeric Hybrid Nanomicelles for Cancer Theranostics: An Efficient and Precise Anticancer Strategy for the Codelivery of Doxorubicin/miR-34a and Magnetic Resonance Imaging. ACS Applied Materials & Interfaces. 11(47). 43865–43878. 33 indexed citations
11.
Shen, Xue, Tingting Li, Zhongyuan Chen, et al.. (2019). NIR-Light-Triggered Anticancer Strategy for Dual-Modality Imaging-Guided Combination Therapy via a Bioinspired Hybrid PLGA Nanoplatform. Molecular Pharmaceutics. 16(3). 1367–1384. 41 indexed citations
13.
Zhang, Dongmei, Gao Zhang, Zhongyi Hu, et al.. (2017). Oncogenic RAS Regulates Long Noncoding RNA Orilnc1 in Human Cancer. Cancer Research. 77(14). 3745–3757. 29 indexed citations
14.
Feng, Yi, et al.. (2017). Changes in body composition in children with acute graft-versus-host disease within the first 100 days after hematopoietic stem cell transplantation. European Journal of Clinical Nutrition. 72(8). 1167–1175. 5 indexed citations
15.
Yan, Ping, Hui Gong, Xiaoyan Zhai, et al.. (2016). Decreasing CNPY2 Expression Diminishes Colorectal Tumor Growth and Development through Activation of p53 Pathway. American Journal Of Pathology. 186(4). 1015–1024. 33 indexed citations
16.
Feng, Yi, Tien-Chi Pan, Dhruv K. Pant, et al.. (2014). SPSB1 Promotes Breast Cancer Recurrence by Potentiating c-MET Signaling. Cancer Discovery. 4(7). 790–803. 33 indexed citations
17.
Alvarez, James V., Tien-Chi Pan, Jason R. Ruth, et al.. (2013). Par-4 Downregulation Promotes Breast Cancer Recurrence by Preventing Multinucleation following Targeted Therapy. Cancer Cell. 24(1). 30–44. 68 indexed citations
18.
Hong, Li, et al.. (2012). Nutrition assessment for 1 201 hospitalized children on a pediatric-surgical ward using modified STAMP scoring system. Zhonghua xiaoerwaike zazhi. 33(10). 742–746. 1 indexed citations
19.
Liang, Xiaobo, Haiyi Liu, Yaoping Li, et al.. (2011). Effectiveness and Safety of Laparoscopic Resection Versus Open Surgery in Patients with Rectal Cancer: A Randomized, Controlled Trial from China. Journal of Laparoendoscopic & Advanced Surgical Techniques. 21(5). 381–385. 56 indexed citations
20.
Cheung, Irene Y., Yi Feng, Neerav Shukla, et al.. (2007). Novel Markers of Subclinical Disease for Ewing Family Tumors from Gene Expression Profiling. Clinical Cancer Research. 13(23). 6978–6983. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026